Research Roundup

Debbie Rigby rounds up the latest in research news Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain The OPTION-DM randomised controlled trail concluded that three commonly used treatment pathways provide comparable patient outcomes at similar costs. Participants were randomised to: (1) amitriptyline supplemented with pregabalin, (2) duloxetine supplemented with pregabalin or (3) pregabalin